Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial

BMJ Open
Reo HamaguchiSatoru Iwase

Abstract

Although adjuvant capecitabine therapy for patients with colorectal cancer after surgery often causes adverse events (AEs), such as diarrhoea, stomatitis, anorexia and hand-foot syndrome (HFS), there are no standard prevention therapies. Cystine and theanine were reported to attenuate some chemotherapy-associated AEs, and are also expected to attenuate the AEs caused by capecitabine treatment. Therefore, our present study aimed to determine the safety and efficacy of cystine/theanine therapy in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery. A multi-institutional, prospective, randomised, double-blinded, placebo-controlled, phase II trial is being planned. Patients with colorectal cancer treated with capecitabine as an adjuvant chemotherapy will be randomised into either the cystine/theanine group (n=50) or placebo group (n=50). Data will be collected during four courses of capecitabine therapy. The primary endpoint will be incidence rate of diarrhoea of grade 1 or higher in accordance with the Common Terminology Criteria for AEs (CTCAE) v.4.0, Japanese Clinical Oncology Group (JCOG) version. The secondary endpoints are incidence rates of other AEs (CTCAE v.4.0-JCOG), scores of...Continue Reading

References

Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L BlumT Griffin
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefano CascinuGiuseppina Catalano
Nov 28, 2002·Clinical Colorectal Cancer·George Pentheroudakis, Chris Twelves
Jul 1, 2005·The New England Journal of Medicine·Chris TwelvesWerner Scheithauer
Sep 14, 2012·JPEN. Journal of Parenteral and Enteral Nutrition·Tomohiro MiyachiTakashi Mikami
Jan 11, 2013·BMJ : British Medical Journal·An-Wen ChanDavid Moher
Jun 20, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M YoshidaUNKNOWN ACTS-CC study group
Jul 1, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ralf-Dieter HofheinzAndreas Schneeweiss
Sep 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M YoshidaUNKNOWN ACTS-CC study group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.